
|Articles|January 21, 2020
CureDuchenne Joins Vivli
Advertisement
CureDuchenne has announced that they will contribute patient-level clinical data for treating muscular dystrophy to the Vivli platform. The data will supplement existing studies that are available to request on the Vivli platform and be available to other researchers around the world.
For more information, click
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
The Confidence Trap in Clinical Trials: When Knowing Just Enough Becomes Dangerous
2
Applied Clinical Trials' 2025 State of the Industry Survey
3
Redefining CRA Workflows Through Intelligent Automation
4
ACT Brief Weekly Recap: Clinical Research Faces Funding Strain, Data Evolution, and a Shift in Outsourcing Models
5